TScan plans to cut 75% of their workforce and pivot to solid tumor cell therapy TScan Therapeutics (Nasdaq: TCRX) announced a strategic reorganization that includes a workforce reduction of approximately 75%, shifting the company’s focus to an in vivo-engineered T...
This looks bad, Global bond sell-off worsens as U.S. 2-year yield touches highest level since 2025 A relentless global bond market sell-off accelerated on Tuesday, driving sovereign borrowing costs across North America, Europe, and Asia to generational highs as...
What a move, Comstock Resource stock rises on $1.65B SOCAR deal Comstock Resources (NYSE: CRK) rose 5% Tuesday after announcing a letter of intent with the State Oil Company of the Azerbaijan Republic (SOCAR) for a $1.65 billion asset sale and a separate $450 million...
